Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular mechanisms regulating human CYP4B1 lung-selective expression.

Mark T Poch1, N Shane Cutler, Garold S Yost

  • 1Department of Pediatrics, Medical College of Wisconsin, 8701 Watertown Plank Rd., Milwaukee, WI 53226, USA. rhines@mail.mcw.edu

Drug Metabolism and Disposition: the Biological Fate of Chemicals
|May 19, 2005
PubMed
Summary

Researchers identified regulatory elements controlling lung-specific CYP4B1 gene expression. Sp1 transcription factors play a key role in lung cells, but not liver cells, for this selective expression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bringing Big Data to Bear in Environmental Public Health: Challenges and Recommendations.

Frontiers in artificial intelligence·2020
Same author

Physiologically Based Pharmacokinetic Modeling in Risk Assessment: Case Study With Pyrethroids.

Toxicological sciences : an official journal of the Society of Toxicology·2020
Same author

Development and Application of a Life-Stage Physiologically Based Pharmacokinetic (PBPK) Model to the Assessment of Internal Dose of Pyrethroids in Humans.

Toxicological sciences : an official journal of the Society of Toxicology·2019
Same author

A Time-Embedding Network Models the Ontogeny of 23 Hepatic Drug Metabolizing Enzymes.

Chemical research in toxicology·2019
Same author

Developmental Expression of the Cytosolic Sulfotransferases in Human Liver.

Drug metabolism and disposition: the biological fate of chemicals·2019
Same author

A Chemical Category-Based Prioritization Approach for Selecting 75 Per- and Polyfluoroalkyl Substances (PFAS) for Tiered Toxicity and Toxicokinetic Testing.

Environmental health perspectives·2019

Area of Science:

  • Pharmacogenomics
  • Molecular Biology
  • Biochemistry

Background:

  • Lung-selective cytochrome P450 (CYP4B1) expression is crucial for drug metabolism.
  • Regulatory mechanisms governing CYP4B1 lung selectivity remain largely unknown.

Purpose of the Study:

  • To identify and characterize regulatory elements controlling CYP4B1 lung-specific expression.
  • To elucidate the transcription factors involved in CYP4B1 regulation.

Main Methods:

  • Transient expression of CYP4B1/luciferase constructs in various cell lines.
  • Competitive electrophoretic mobility shift assays (EMSA) and in vitro DNA/protein binding assays.
  • Chromatin immunoprecipitation (ChIP) assays in human lung and liver tissues.

Main Results:

Related Experiment Videos

  • Identified proximal (-139 to -45) and distal (-1087 to -1008) positively acting regulatory elements for CYP4B1.
  • Localized Sp1 and Sp3 transcription factor binding sites within the proximal element.
  • Demonstrated lung-selective Sp1 binding to the CYP4B1 promoter in vivo, contrasting with liver tissue.

Conclusions:

  • Proximal Sp1 elements and a distal regulatory element synergistically control CYP4B1 lung-selective expression.
  • Sp1 transcription factor plays a critical role in mediating CYP4B1 lung specificity.